Vidaza Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Vidaza Side Effects
Did You Have Vidaza Side Effect? |
Vidaza Side Effects Poll Results | ||||||||
|
Vote Below:
|
Have you experienced side effects?
|
95%Vidaza Comments and Questions
Comments to date: 1. Page 1 of 1.
John P. Location unknown | 8:33pm on Tuesday, September 23rd, 2008 |
My 73 yo mother was diagnosed with myelodysplasia three months ago. After failing to respond to the ... read more » | |
Ask Community about Vidaza:
What is Your Question? Ask Community:
Daily Health Videos
Vidaza Side Effects reported on Patientsville.com
Vidaza Side Effects reported to FDA
< Previous Showing 101-150 of 226 Next >
Vidaza Side Effects Report #5518412-1Pharmacist from UNITED STATES reported Vidaza side effect on Nov 13, 2007. Female patient, 60 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hepatitis
, pancytopenia, renal failure acute. Vidaza dosage: 160 MG DAILY SQ. During the same period patient was treated with EFFEXOR, ISOSORBIDE MONONITRATE, LASIX, LISINOPRIL, SPIRONOLACTONE, ASPIRIN, NEURONTIN, TOPROL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5524786-8
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Nov 01, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pulmonary embolism
. Vidaza dosage: (156 MG), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5526552-6
Pharmacist from UNITED STATES reported Vidaza side effect on Nov 21, 2007. Male patient, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, insomnia, pneumonia
, refusal of treatment by relative, respiratory failure, tachycardia, tuberculosis . Vidaza dosage: 230MG DAILY IV; 10 CYLES. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.Vidaza Side Effects Report #5528530-X
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Nov 06, 2007. Female patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: neutropenic sepsis, white blood cell count increased. Vidaza dosage: (130 MG, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE. Patient was hospitalized. Patient died on 09/03/2007.
Vidaza Side Effects Report #5534154-0
Physician from UNITED KINGDOM reported Vidaza side effect on Nov 15, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, international normalised ratio decreased, pulmonary embolism
. Vidaza dosage: (156 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5548199-8
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2007. Male patient, 63 years of age, was treated with Vidaza. After drug was administered, patient experienced the following side effects: neutropenia, pancreatitis acute. Vidaza dosage: 37.5 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, CETIRIZINE, FOLIC ACID, FLUOXETINE, OMEPRAZOLE, DOMPERIDONE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5563347-1
Physician from UNITED STATES reported Vidaza side effect on Oct 23, 2007. Female patient, 78 years of age, weighting 141.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, platelet count decreased, urinary tract infection
. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5569917-9
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Dec 04, 2007. Male patient, 63 years of age, was diagnosed with cytogenetic abnormality and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pancreatitis acute. Vidaza dosage: 37.5 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, CETIRIZINE, FOLIC ACID, FLUOXETINE, OMEPRAZOLE, DOMPERIDONE, PROCHLORPERAZINE MALEATE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5571889-8
Physician from UNITED STATES reported Vidaza side effect on Dec 05, 2007. Male patient, 67 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection
, culture positive, febrile neutropenia, mucormycosis. Vidaza dosage: (200 MG, DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with TERAZOSIN, OSTEO BIFLEX, ASPIRIN, FOLIC ACID, GLYBURIDE, MAGNESIUM, ZETIA, VITAMIN B12. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5578214-7
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, platelet count decreased, pulmonary embolism
. Vidaza dosage: 156 MG, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDOFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5592611-5
Physician from UNITED STATES reported Vidaza side effect on Jan 02, 2008. Male patient, 63 years of age, weighting 257.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cholelithiasis, hepatitis
, iron overload, splenomegaly. Vidaza dosage: 90 MG/M2, DAILY X5, SUBCUTANEOUS. During the same period patient was treated with AMARYL, FOLIC ACID, HUMULIN, SENOKOT, MEGACE. Patient recovered.Vidaza Side Effects Report #5603369-5
Vidaza side effect was reported by a Pharmacist from GERMANY on Jan 10, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: injection site cellulitis, injection site nodule, vasculitis necrotising. Vidaza dosage: (75 MG/M2), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5610455-2
Health Professional from UNITED STATES reported Vidaza side effect on Jan 21, 2008. Male patient, 65 years of age, weighting 176.8 lb, was diagnosed with myeloproliferative disorder and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain
, necrosis, rash , refusal of treatment by patient, splenic infarction. Vidaza dosage: 75 MG/M2, DAILY, INTRAVENOUS. During the same period patient was treated with PROCHLORPERAZINE MALEATE, DOCUSATE, SENNA, FIBERCON. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5611096-3
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 16, 2008. Female patient, 53 years of age, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hepatitis
. Vidaza dosage: (32 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PENTAMIDINE ISETHIONATE, POSACONAZOLE, MYLOTARG, FLUDARABINE PHOSPHATE, MELPHALAN, ATIVAN, CALCIUM GLUCONATE, CARBONATE. Patient recovered.Vidaza Side Effects Report #5614727-7
Physician from UNITED STATES reported Vidaza side effect on Jan 17, 2008. Male patient, 56 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, pneumocystis jiroveci pneumonia, refusal of treatment by relative, respiratory failure, tachycardia. Vidaza dosage: 230 MG, DAILY. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.
Vidaza Side Effects Report #5626392-3
Vidaza side effect was reported by a Physician from GERMANY on Feb 01, 2008. Female patient, 68 years of age, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, cachexia, confusional state, diarrhoea, leukoencephalopathy, thrombocytopenia. Vidaza dosage: (75 MG/M2, DAILY X7 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5635722-8
Physician from LEBANON reported Vidaza side effect on Feb 08, 2008. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Vidaza dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE. Patient died on 02/02/2008.
Vidaza Side Effects Report #5643881-6
Vidaza side effect was reported by a Health Professional from UNITED STATES on Feb 14, 2008. Male patient, 65 years of age, weighting 176.4 lb, was diagnosed with myeloproliferative disorder and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain
, bone marrow disorder, cerebrovascular accident, musculoskeletal pain, necrosis, rash erythematous, respiratory disorder, splenic infarction. Vidaza dosage: 75 MG/M2,DAILY X 5 DAYS , INTRAVENOUS. During the same period patient was treated with PROCHLORPERAZINE MALEATE, DOCUSATE, SENNA, FIBERCON, BENADRYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5646849-9
Physician from ITALY reported Vidaza side effect on Feb 18, 2008. Male patient, 80 years of age, weighting 213.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: renal failure, sepsis
. Vidaza dosage: (150 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with DEPAKIN. Patient was hospitalized. Patient died on 01/16/2008.Vidaza Side Effects Report #5648090-2
Vidaza side effect was reported by a Physician from LEBANON on Feb 25, 2008. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute myocardial infarction. Vidaza dosage: 50 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with BISOPROLOL FUMARATE. Patient died on 02/02/2008.
Vidaza Side Effects Report #5663639-1
Physician from UNITED KINGDOM reported Vidaza side effect on Feb 27, 2008. Female patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: confusional state, lower respiratory tract infection, neutropenic sepsis. Vidaza dosage: (130 MG, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE. Patient was hospitalized. Patient died on 09/03/2007.
Vidaza Side Effects Report #5663653-6
Vidaza side effect was reported by a Physician from GERMANY on Feb 27, 2008. Female patient, 68 years of age, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, cachexia, diarrhoea, leukoencephalopathy, performance status decreased, thrombocytopenia. Vidaza dosage: 75 MG/M2, DAILY X 7, SUBCUTANEOUS. During the same period patient was treated with ACYCLOVIR, ESOMEPRAZOLER, COTRIMTE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5664333-3
Physician from UNITED STATES reported Vidaza side effect on Feb 28, 2008. Male patient, 67 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection
, cellulitis , eye infection , eye infection fungal, febrile neutropenia, sinus headache. Vidaza dosage: (200 MG,DAILY X DAYS), INTRAVENOUS. During the same period patient was treated with TERAZOSIN, OSTEO BIFLEX, ASPIRIN, FOLIC ACID, GLYBURIDE, MAGNESIUM, ZETIA, VITAMIN B12. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5673991-9
Vidaza side effect was reported by a Pharmacist from UNITED STATES on Mar 19, 2008. Female patient, 76 years of age, weighting 154.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain
, acute myocardial infarction, breast cancer female, coagulopathy, disseminated intravascular coagulation, gastrointestinal haemorrhage, gastrointestinal necrosis, haematemesis, hypotension. Vidaza dosage: 170 MG DAILY X 5 DAYS EVERY 28 DAYS IV. During the same period patient was treated with NORVASC, SYNTHROID, VIT D, EVISTA. Patient was hospitalized. Patient died on 11/22/2007.Vidaza Side Effects Report #5689761-1
Physician from UNITED STATES reported Vidaza side effect on Mar 19, 2008. Male patient, 71 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardiac tamponade, hyperkalaemia, metabolic acidosis, pericarditis, renal failure acute, septic shock, staphylococcal infection
. Vidaza dosage: (75 MG/M2,DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with KYTRIL, ANIDULAFUNGIN, AZITHROMYCIN, FLORINEF, HYDROCORTISONE, INSULIN, MEROPENEM, VANCOMYCIN. Patient was hospitalized. Patient died on 03/15/2008.Vidaza Side Effects Report #5710716-2
Vidaza side effect was reported by a Physician from FRANCE on Mar 31, 2008. Male patient, 72 years of age, weighting 178.6 lb, was diagnosed with myelodysplastic syndrome, neutropenia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: apnoea, bronchial obstruction, interstitial lung disease, pulmonary fibrosis
, pulmonary function test abnormal. Vidaza dosage: (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with GRANOCYTE, DEPAKENE, VESANOID, SECTRAL, ALLOPURINOL, PANTOPRAZOLE, RENITEC, FORLAX. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5713661-1
Physician from SWITZERLAND reported Vidaza side effect on Apr 03, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: dermatitis, skin ulcer. Vidaza dosage: 100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VITAMIN B12. Patient recovered.
Vidaza Side Effects Report #5717178-X
Vidaza side effect was reported by a Physician from UNITED STATES on Apr 12, 2008. Male patient, 71 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anuria, cardiac tamponade, hyperkalaemia, metabolic acidosis, pericarditis, renal failure acute, septic shock, staphylococcal infection
. Vidaza dosage: (75 MG/M2, DAILY X 5 DAYS) INTRAVENOUS. During the same period patient was treated with KYTRIL, ANIDULAFUNGIN, AZITHROMYCIN, FLORINEF, HYDROCORTISONE, INSULIN, MEROPENEM, VANCOMYCIN. Patient was hospitalized. Patient died on 03/15/2008.Vidaza Side Effects Report #5723350-5
Physician from SWITZERLAND reported Vidaza side effect on Apr 18, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: dermatitis, skin discolouration, skin injury. Vidaza dosage: (100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS, (100 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with VITAMIN B12. Patient recovered.
Vidaza Side Effects Report #5730345-4
Vidaza side effect was reported by a Physician from FRANCE on Apr 24, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: type 1 diabetes mellitus. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with DEPAKENE, VESANOID, FOLIC ACID, ATORVASTATIN CALCIUM, SERENOA REPENS, RAUBASINE DIHYDROERGOCRISTINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5738425-4
Physician from UNITED STATES reported Vidaza side effect on Apr 30, 2008. Male patient, 75 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, hilar lymphadenopathy, lymphadenopathy mediastinal, pharyngitis streptococcal, prothrombin time prolonged, pulmonary embolism
. Vidaza dosage: 75 MG/M2, DAILY X 5,SUBCUTANEOUS. During the same period patient was treated with OXYCODONE, CARTIA XT, HYDRALAZINE, ANAGRELIDE, LASIX, COUMADIN, POTASSIUM, VITAMIN B12. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5744798-9
Vidaza side effect was reported by a Physician from UNITED STATES on May 02, 2008. Female patient, 77 years of age, weighting 134.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: colitis ischaemic. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with VITAMIN, FERROUS SULPHATE, ESOMEPRAZOLE, OXYCODONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5760654-4
Physician from UNITED STATES reported Vidaza side effect on May 23, 2008. Female patient, 77 years of age, weighting 134.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: colitis ischaemic, rectal haemorrhage. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with VITAMIN, FERROUS SULPHATE, ESOMEPRAZOLE, OXYCODONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5762001-0
Vidaza side effect was reported by a Physician from FRANCE on May 19, 2008. Male patient, 76 years of age, weighting 125.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aplasia pure red cell, lobar pneumonia, no therapeutic response, pleural effusion. Vidaza dosage: 100 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FERRIPROX, IMOVANE, LACTEOL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5762002-2
Physician from FRANCE reported Vidaza side effect on May 20, 2008. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, complications of bone marrow transplant, cytolytic hepatitis, renal failure. Vidaza dosage: 75 MG/M2, DAILY, SUBCUTANEOUS. During the same period patient was treated with ROVAMYCINE, VALACYCLOVIR, CORTICOSTEROIDS, GRANOCYTE, AUGMENTIN, AMOXICILLIN. Patient recovered.
Vidaza Side Effects Report #5762004-6
Vidaza side effect was reported by a Physician from FRANCE on May 21, 2008. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: interstitial lung disease. Vidaza dosage: 150 MG, DAILY, X 7, SUBCUTANEOUS. During the same period patient was treated with HYDREA, GLYBURIDE, TENORMIN, PRAVASTATIN, ASPEGIC, OMEPRAZOLE, PREVISCAN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5766018-1
Physician from UNITED STATES reported Vidaza side effect on May 23, 2008. Female patient, 66 years of age, weighting 187.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: breast haematoma, ecchymosis, epistaxis, idiopathic thrombocytopenic purpura, injection site induration, injury, karyotype analysis abnormal, neutropenia, pancytopenia. Vidaza dosage: (50 MG/M2, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with COMPAZINE, VITAMINS. Patient recovered.
Vidaza Side Effects Report #5767809-3
Vidaza side effect was reported by a Physician from FRANCE on May 26, 2008. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: glycosylated haemoglobin increased, type 1 diabetes mellitus. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS) ,SUBCUTANEOUS. During the same period patient was treated with DEPAKENE, VESANOID, FOLIC ACID, ATORVASTATIN CALCIUM, SERENOA REPENS, RAUBASINE DIHYDROERGOCRISTINE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5771531-7
Pharmacist from GERMANY reported Vidaza side effect on May 30, 2008. Male patient, 64 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abscess
, injection site necrosis, injection site nodule, injection site vasculitis. Vidaza dosage: (75 MG/M2), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5771533-0
Vidaza side effect was reported by a Health Professional from FRANCE on June 02, 2008. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: interstitial lung disease. Vidaza dosage: (150 MG DAILY X 7), SUBCUTANEOUS. During the same period patient was treated with HYDREA, GLYBURIDE, TENORMIN, PRAVASTATIN, ASPEGIC, OMEPRAZOLE, PREVISCAN. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5777991-X
Physician from UNITED STATES reported Vidaza side effect on June 04, 2008. Female patient, 72 years of age, weighting 123.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, pancytopenia. Vidaza dosage: 120 MG/M2, DAILY X 7 DAYS, INTRAVENOUS. During the same period patient was treated with LISINOPRIL, FUROSEMIDE, CYCLOSPORINE, CARVEDILOL, PREDNISONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5803583-X
Vidaza side effect was reported by a Physician from GERMANY on June 18, 2008. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: lung infiltration, neutropenia, respiratory failure. Vidaza dosage: (143 MG, X 5 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient died on 06/17/2008.
Vidaza Side Effects Report #5804010-9
Physician from UNITED STATES reported Vidaza side effect on June 19, 2008. Male patient, 81 years of age, weighting 167.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, condition aggravated, hypoxia, lobar pneumonia, neutropenia. Vidaza dosage: (75 MG/M2,DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with COMPAZINE, LISINOPRIL, NIFEDIPINE, METOPROLOL SUCCINATE, FUROSEMIDE, SYNTHROID, ASPIRIN, CORGARD. Patient was hospitalized. Patient died on 04/12/2008.
Vidaza Side Effects Report #5804541-1
Vidaza side effect was reported by a Physician from GERMANY on June 24, 2008. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: lung infiltration, neutropenia, respiratory failure, white blood cell count decreased. Vidaza dosage: (143 MG, 5 D, SUBCUTANEOUS). Patient was hospitalized. Patient died on 06/17/2008.
Vidaza Side Effects Report #5811410-X
Health Professional from UNITED STATES reported Vidaza side effect on July 15, 2008. Female patient, 26 years of age, was treated with Vidaza. After drug was administered, patient experienced the following side effects: accidental exposure. Vidaza dosage: unknown. Patient recovered.
Vidaza Side Effects Report #5811510-4
Vidaza side effect was reported by a Physician from ESTONIA on July 04, 2008. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pulmonary fibrosis
. Vidaza dosage: (200 MG/M2), SUBCUTANEOUS. During the same period patient was treated with DEFLAZACORTE, OMEPRAZOLE, AUGMENTIN. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5814322-0
Physician from UNITED STATES reported Vidaza side effect on July 01, 2008. Female patient, 60 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, ascites, bronchogram abnormal, dyspnoea exertional, mental status changes, platelet count decreased, pneumonia
, postnasal drip. Vidaza dosage: 44 MG, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with MYLOTARG, FLUDARABINE PHOSPHATE, MELPHALAN, AMPHOTERICIN B LIPOSOMAL, ANIDULAFUNGIN, AZITHROMYCIN, CEFEPIME, FOSCARNET. Patient was hospitalized. Patient died on 06/23/2008.Vidaza Side Effects Report #5824190-9
Vidaza side effect was reported by a Pharmacist from FRANCE on July 11, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. Vidaza dosage: (75 MG/M2), SUBCUTANEOUS. Patient died.
Vidaza Side Effects Report #5827786-3
Pharmacist from FRANCE reported Vidaza side effect on July 23, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.
Vidaza Side Effects Report #5827995-3
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2008. Male patient, 86 years of age, weighting 145.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemoglobin decreased, intestinal perforation, mental disorder, mood altered. Vidaza dosage: (50 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
< Previous Showing 101-150 of 226 Next >